Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

8.410 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20
Open 8.410
Bid (Size) 8.400 (5)
Ask (Size) 9.330 (2)
Prev. Close 8.410
Today's Range 8.410 - 8.410
52wk Range 7.440 - 10.90
Shares Outstanding 49,471,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Beats Revenue for Q1 2024
TBPH stock results show that Theravance Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
BTIG Research Predicts Over 118% Rally for These 3 Stocks
Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money. 
Via InvestorPlace

Performance

YTD
-9.4%
-9.4%
1 Month
-3.7%
-3.7%
3 Month
-10.1%
-10.1%
6 Month
-13.1%
-13.1%
1 Year
-10.4%
-10.4%

More News

Read More
Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
Via InvestorPlace
Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Unveiling 4 Analyst Insights On Theravance Biopharma
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma
Via Benzinga
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Recap: Theravance Biopharma Q4 Earnings
Via Benzinga
A Preview Of Theravance Biopharma's Earnings
Via Benzinga
Earnings Scheduled For February 26, 2024
Via Benzinga
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
7 Short-Squeeze Stocks That Are Screaming for Speculation
Via InvestorPlace
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
Via Talk Markets
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 7, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga

Frequently Asked Questions

Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
The current price of Theravance Biopharma, Inc. - Ordinary Shares is 8.410
When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 05/14/25 04:00 PM ET
What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 416.05M
How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
Theravance Biopharma, Inc. - Ordinary Shares has 416M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.